Brenus Pharma
PrivateLast Round
Series A
Jul 30, 2026
Total Funding Raised
$47.47M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Brenus Pharma is a clinical-stage biotechnology company that develops allogeneic cancer vaccines using its proprietary 'Stimulated-Tumor-(ghost)-Cells' (STC) platform to educate the immune system to target and destroy cancer cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Brenus Pharma Comparables
Compare Brenus Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Imvax | 80% | |
| NEUVOGEN, Inc. | 79% | |
| PDC*line Pharma | 79% |
Brenus Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jul 30, 2026 | ||||
| Series A | Sep 18, 2024 | ||||
| Grant | Jan 22, 2024 | ||||
| Seed | Mar 17, 2022 |
Key People
Founding team and executive leadership
Brenus Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | Series A |
| Investsud | Series A |
| Kreaxi | Series A |
| Korea Omega Investment Corp | Series A |
| Financière Spin-off Luxembourgeoise | Series A |
| French Ministry of the Economy, Finance and Industrial and Digital Sovereignty | Grant |
| Angelor | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 15, 2026
Grew 15% QoQ, from 26 to 30 employees.
- Jul 30, 2026
$13M round with UI Investissement and Angelor
Recent news
Latest coverage and updates
- is_developingJul 22, 2026
Brenus Pharma is developing off-the-shelf platform on Jul 22nd '26.
- receives_financingJul 21, 2026
Brenus Pharma received financing of $12.6M in Series A1 on Jul 21st '26.
- receives_financingJul 21, 2026
Brenus Pharma received financing of $12.6M in Series A on Jul 21st '26.
Brenus Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Brenus Pharma's valuation, stock price, and market status.
Is Brenus Pharma a public or private company?
Brenus Pharma is a private company.
What is the current stock price of Brenus Pharma?
Brenus Pharma is a private company with no public stock price. No recent secondary market data is available.
How much is Brenus Pharma worth (valuation)?
Valuation information for Brenus Pharma is not publicly available.
Can I buy Brenus Pharma stock?
Brenus Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Brenus Pharma's last funding round?
Brenus Pharma's most recent funding round was Series A on September 18, 2024.
Who are the main investors in Brenus Pharma?
Key investors in Brenus Pharma include Angelor.
Will Brenus Pharma IPO soon?
No public IPO plans have been announced for Brenus Pharma.
How can I track Brenus Pharma secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Brenus Pharma's secondary market activity and sign up for updates.